Medlive Technology Co., Ltd. (HKG:2192)

Medlive Technology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,996	7,270	6,165	6,119	19,400	-
Market Cap Growth	26.41%	17.93%	0.75%	-68.46%	-	-
Enterprise Value	5,109	3,186	1,443	1,384	19,201	-
Last Close Price	12.19	9.70	8.02	7.88	25.07	-
PE Ratio	25.32	21.68	23.09	46.14	389.12	-
Forward PE	24.85	24.68	47.25	45.73	138.82	-
PS Ratio	13.09	12.23	13.58	17.24	55.56	-
PB Ratio	1.68	1.41	1.21	1.22	3.98	-
P/TBV Ratio	1.79	1.49	1.28	1.27	4.08	-
P/FCF Ratio	61.42	70.90	55.34	71.37	372.18	-
P/OCF Ratio	53.09	63.07	54.93	70.12	355.69	-
EV/Sales Ratio	7.43	5.36	3.18	3.90	55.00	-
EV/EBITDA Ratio	31.42	24.81	19.01	19.84	245.44	-
EV/EBIT Ratio	35.49	25.49	20.16	20.47	253.93	-
EV/FCF Ratio	34.88	31.07	12.96	16.15	368.37	-
Debt / Equity Ratio	0.00	0.01	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.10	0.17	0.11	0.17	0.20	0.11
Debt / FCF Ratio	0.11	0.24	0.08	0.15	0.31	0.11
Asset Turnover	0.13	0.11	0.09	0.07	0.13	1.25
Inventory Turnover	-	-	1078.32	691.56	-	-
Quick Ratio	20.58	20.89	24.04	32.74	35.42	3.23
Current Ratio	20.65	21.04	24.10	32.78	35.45	3.25
Return on Equity (ROE)	7.02%	6.95%	5.55%	3.01%	2.19%	78.29%
Return on Assets (ROA)	1.63%	1.47%	0.86%	0.86%	1.77%	37.96%
Return on Invested Capital (ROIC)	9.85%	23.44%	27.58%	38.18%	92.12%	374.08%
Return on Capital Employed (ROCE)	2.70%	2.40%	1.40%	1.30%	1.50%	63.50%
Earnings Yield	3.94%	4.61%	4.33%	2.17%	0.26%	-
FCF Yield	1.63%	1.41%	1.81%	1.40%	0.27%	-
Dividend Yield	2.36%	2.82%	3.18%	0.94%	0.08%	-
Payout Ratio	58.20%	56.81%	51.46%	10.34%	226.51%	-
Buyback Yield / Dilution	-0.12%	-0.23%	0.26%	-15.84%	-18.82%	0.07%
Total Shareholder Return	2.24%	2.59%	3.44%	-14.90%	-18.74%	0.07%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.